Summit Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $367K | Sell |
6,059
-50
| -0.8% | -$2.92K | 0.05% | 128 |
|
|
2025
Q4 | $330K | Buy |
6,109
+15
| +0.2% | +$722 | 0.05% | 134 |
|
|
2025
Q3 | $275K | Sell |
6,094
-566
| -8% | -$26.4K | 0.04% | 142 |
|
|
2025
Q2 | $308K | Sell |
6,660
-3,035
| -31% | -$149K | 0.05% | 135 |
|
|
2025
Q1 | $591K | Buy |
9,695
+1,783
| +23% | +$104K | 0.1% | 91 |
|
|
2024
Q4 | $448K | Hold |
7,912
| – | – | 0.08% | 105 |
|
|
2024
Q3 | $409K | Sell |
7,912
-31
| -0.4% | -$1.45K | 0.08% | 111 |
|
|
2024
Q2 | $330K | Hold |
7,943
| – | – | 0.07% | 118 |
|
|
2024
Q1 | $431K | Sell |
7,943
-555
| -7% | -$28.3K | 0.09% | 99 |
|
|
2023
Q4 | $436K | Buy |
8,498
+600
| +8% | +$31.5K | 0.1% | 92 |
|
|
2023
Q3 | $458K | Hold |
7,898
| – | – | 0.12% | 86 |
|
|
2023
Q2 | $505K | Sell |
7,898
-153
| -2% | -$10.3K | 0.13% | 80 |
|
|
2023
Q1 | $558K | Buy |
8,051
+1
| +0% | +$71 | 0.15% | 75 |
|
|
2022
Q4 | $579K | Buy |
8,050
+1
| +0% | +$75 | 0.17% | 73 |
|
|
2022
Q3 | $572K | Buy |
8,049
+76
| +1% | +$5.51K | 0.18% | 70 |
|
|
2022
Q2 | $614K | Buy |
7,973
+75
| +0.9% | +$5.71K | 0.19% | 69 |
|
|
2022
Q1 | $577K | Buy |
7,898
+800
| +11% | +$53.7K | 0.17% | 80 |
|
|
2021
Q4 | $443K | Sell |
7,098
-682
| -9% | -$40K | 0.13% | 97 |
|
|
2021
Q3 | $460K | Sell |
7,780
-545
| -7% | -$35.9K | 0.14% | 82 |
|
|
2021
Q2 | $556K | Sell |
8,325
-160
| -2% | -$10.4K | 0.17% | 74 |
|
|
2021
Q1 | $536K | Sell |
8,485
-80
| -0.9% | -$4.98K | 0.18% | 74 |
|
|
2020
Q4 | $531K | Buy |
8,565
+845
| +11% | +$52K | 0.19% | 72 |
|
|
2020
Q3 | $465K | Buy |
7,720
+1,439
| +23% | +$86.6K | 0.19% | 68 |
|
|
2020
Q2 | $369K | Sell |
6,281
-71
| -1% | -$4.25K | 0.17% | 73 |
|
|
2020
Q1 | $354K | Buy |
6,352
+255
| +4% | +$15.6K | 0.19% | 70 |
|
|
2019
Q4 | $391K | Hold |
6,097
| – | – | 0.17% | 70 |
|
|
2019
Q3 | $309K | Hold |
6,097
| – | – | 0.14% | 78 |
|
|
2019
Q2 | $276K | Sell |
6,097
-330
| -5% | -$15.4K | 0.13% | 85 |
|
|
2019
Q1 | $307K | Sell |
6,427
-230
| -3% | -$11.5K | 0.15% | 77 |
|
|
2018
Q4 | $346K | Sell |
6,657
-175
| -3% | -$9.4K | 0.2% | 66 |
|
|
2018
Q3 | $424K | Hold |
6,832
| – | – | 0.2% | 64 |
|
|
2018
Q2 | $378K | Sell |
6,832
-169
| -2% | -$9.13K | 0.18% | 66 |
|
|
2018
Q1 | $443K | Sell |
7,001
-74
| -1% | -$4.76K | 0.21% | 61 |
|
|
2017
Q4 | $434K | Sell |
7,075
-134
| -2% | -$8.38K | 0.21% | 65 |
|
|
2017
Q3 | $459K | Sell |
7,209
-173
| -2% | -$10.1K | 0.23% | 61 |
|
|
2017
Q2 | $411K | Sell |
7,382
-400
| -5% | -$21.8K | 0.22% | 66 |
|
|
2017
Q1 | $423K | Sell |
7,782
-494
| -6% | -$27.1K | 0.24% | 60 |
|
|
2016
Q4 | $484K | Hold |
8,276
| – | – | 0.3% | 54 |
|
|
2016
Q3 | $446K | Buy |
8,276
+20
| +0.2% | +$1.28K | 0.27% | 55 |
|
|
2016
Q2 | $607K | Sell |
8,256
-280
| -3% | -$19.8K | 0.39% | 41 |
|
|
2016
Q1 | $545K | Hold |
8,536
| – | – | 0.36% | 44 |
|
|
2015
Q4 | $587K | Sell |
8,536
-511
| -6% | -$33.8K | 0.4% | 41 |
|
|
2015
Q3 | $536K | Hold |
9,047
| – | – | 0.38% | 46 |
|
|
2015
Q2 | $602K | Sell |
9,047
-6
| -0.1% | -$395 | 0.41% | 43 |
|
|
2015
Q1 | $584K | Buy |
9,053
+460
| +5% | +$28.8K | 0.41% | 41 |
|
|
2014
Q4 | $507K | Sell |
8,593
-276
| -3% | -$15.6K | 0.37% | 45 |
|
|
2014
Q3 | $454K | Sell |
8,869
-200
| -2% | -$9.99K | 0.35% | 47 |
|
|
2014
Q2 | $440K | Sell |
9,069
-200
| -2% | -$9.86K | 0.34% | 44 |
|
|
2014
Q1 | $482K | Sell |
9,269
-100
| -1% | -$5.32K | 0.39% | 41 |
|
|
2013
Q4 | $498K | Hold |
9,369
| – | – | 0.39% | 39 |
|
|
2013
Q3 | $434K | Sell |
9,369
-325
| -3% | -$14.3K | 0.38% | 41 |
|
|
2013
Q2 | $433K | Buy |
+9,694
| New | +$421K | 0.42% | 35 |
|
Other funds holding BMY
VCM
VPM
Summit Asset Management's BMY Position: Q1 2026 in Review
Summit Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.82% in Q1 2026, selling an estimated $2.92K and leaving 6,059 shares worth $367K. The position accounts for 0.05% of the portfolio, ranked #128.
Summit Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $614K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Summit Asset Management held 6,059 shares of Bristol-Myers Squibb worth $367K as of Q1 2026.
- Summit Asset Management sold 50 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.92K.
- Bristol-Myers Squibb made up 0.05% of Summit Asset Management's portfolio in Q1 2026, its #128 holding.
- Summit Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Summit Asset Management's Bristol-Myers Squibb position peaked at $614K in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Summit Asset Management's 13F filing for Q1 2026, filed 8 May 2026.